Weekly Roundup: Insulet Jumps, Disney Surges, Palantir Disappoints | Stock Movers
May 10, 2025
228
2
0.88%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Podcasts Episodes Around May 10, 2025
See what was published immediately before and after this episode.
3:18Now PlayingWeekly Roundup: Insulet Jumps, Disney Surges, Palantir Disappoints | Stock Movers
YouTube Description
as posted by the channelOn this episode of Stock Movers:
- Insulet (PODD) shares rallied this week, soaring up as much as 20% during trading on an upbeat earnings report. The insulin delivery system maker boosted its revenue guidance for the full year and posted better-than-expected first-quarter results. Piper Sandler views the guidance increase positively and as more evidence of strong momentum in the business.
- Disney (DIS) shares rose after it reported fiscal second-quarter results that beat Wall Street estimates and raised its outlook for the full year, citing strong performances from theme parks and streaming TV. Full-year 2025 earnings, excluding certain items, will rise 16% to $5.75 a share, Disney said Wednesday in a statement, about double its previous forecast for growth. Analysts were looking for $5.44 a share. A number of major companies have pulled their 2025 guidance amid the uncertainty caused by US President Donald Trump’s tariffs on imported goods. But Disney is benefiting from faster-than-expected growth at its namesake parks and streaming business, and pointed to that strong performance to boost its guidance.
- Palantir (PLTR) shares slid by the most in nearly a year after its financial results and projections failed to live up to investors’ lofty expectations. The company described rising demand for artificial intelligence software as a “ravenous whirlwind” and bumped its 2025 revenue forecast on Monday to about $3.9 billion from about $3.75 billion. But even a solid earnings results beat and the raised outlook wasn’t enough to justify the stock’s high valuation and extend its massive year-to-date gain. Palantir’s shares tanked by as much as 14.9% to $105.32, the lowest intraday price since May 7, 2024. The stock was still up 41% for the year.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Weekly Roundup: Insulet Jumps, Disney Surges, Palantir Disappoints
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.